NCT05515185

An Open, Single-arm Clinical Study of Autologous T Cells (CAR-T) Targeting B7-H3 Chimeric Antigen Receptor Gene in the Treatment of Patients With Advanced Gastrointestinal Tumors

Study Summary

This is a clinical study to evaluate the safety and efficacy of CAR-T cells in the treatment of patients with advanced solid tumors in China.

Want to learn more about this trial?

Request More Info

Interventions

KT095 CAR-T injectionDRUG
Clearance of lymphocytes

Study Locations

FacilityCityStateCountry
Lianyungang First People's HospitalLianyungangJiangsuChina

Official Trial Information

View on ClinicalTrials.gov

Data sourced from ClinicalTrials.gov. Last updated: April 14, 2026